Who We Are
Principals:
Dr. John Dougherty, founder of Medical Interactive Education, the ALZselftest and Medical Director of the Cole Neuroscience Center (Memory Disorder Program) at the University of Tennessee Medical Center in Knoxville, has had extensive clinical experience and varied leadership roles in the medical field. He earned his undergraduate degree at the University of North Carolina and his medical degree from the University of Tennessee Medical School in Memphis. He trained at Cornell University New York Hospital in Neurology and completed a two-year fellowship at Cornell in cerebrovascular disease.
Dr. Dougherty is an Assistant Professor of Medicine in Neurology at the University of Tennessee and is co-director of the Brain and Spine Institute at the University of Tennessee Medical Center. For the past 10 years he has specialized in dementia and Alzheimer’s disease and has published numerous articles on those topics.
Andrew Dougherty is co-founder of Medical Interactive Education and the ALZselftest. He studied finance and information systems at Tulane University and received his M.B.A. with concentrations in finance and in innovation and entrepreneurship from the University of Tennessee at Knoxville. He works as a consultant for a national venture capital fund, assisting in developing financial models, business plans, and market strategies. He has worked with several startup companies with experience in multiple industries. Additionally, he developed and implemented the plan for marketing the ALZselftest, a computer based cognitive screening test. Andrew started his research and interest in Alzheimer’s disease by volunteering at the Alzheimer’s Association day care program. He then went on to work in the Brain Bank at the University of Tennessee researching the epidemiology behind Alzheimer’s disease. He has given numerous talks on screening and the prevention of Alzheimer’s disease throughout the community.
Director of Cognitive Research and Testing
Rex L. Cannon, Ph.D. received his B.A., M.A. and Ph.D. from the University of Tennessee at Knoxville. He is an Assistant Research Professor in the Department of Psychology and director of the clinical neuroscience laboratory at UT and director of the cognitive neuroscience laboratory at Cole Neuroscience Center, Memory Disorder Clinic. He completed his Ph.D. in experimental psychology with an emphasis in neuroscience methods, neurophysiology and biological psychology.
Dr. Cannon is author of several book chapters and has published numerous neuroscience papers in peer-reviewed journals, including the first work demonstrating that human beings can learn to change the electrical activity in specific regions within the cortex using spatial specific neuro-operant learning. He has received awards for research presentations and was recently nominated by the National Institute of Drug Abuse for a young investigator award. Dr. Cannon has collaborated on a book chapter about the efficacy of neurofeedback for treatment of substance use disorders, and is developing statistical models for reporting psychotherapy and addiction treatment efficacy. He received several awards during his graduate training, including the Cureton Award for outstanding scholarship in the areas of psychometrics and neuropsychology.
Dr. Cannon has presented research at Columbia University and Harvard Medical School. More recently, he has introduced a standard protocol for assessing treatment outcomes for psychiatric syndromes. He has developed chemical dependency assessment instruments and a treatment model incorporating standardized group therapy and spatial-specific neurofeedback training.
Doug Graham – Director of Business Development
Doug Graham recently joined the Medinteract team after spending many years in the pharmaceutical industry. Doug started out in field sales, first in the doctor based market and then on to teaching hospitals. Doug then moved on to positions in sales training, recruiting and finally sales management where he spent the last 13 years. Throughout his career, Doug was involved in different aspects of the pharmaceutical product cycle from market research to pull through in the commercial segment.
Doug was raised in New Jersey and earned a degree in Economics from UNC Charlotte.
